Skip main navigation

Military Health System

MHS GENESIS Patient Portal login is changing

myAuth is replacing DS Logon on Sept. 23, giving you a more secure and easier way to access the MHS GENESIS Patient Portal. Get familiar with myAuth now so you know what to expect the next time you log in. Need help? Contact DMDC Support at 800-368-3665.

Skip subpage navigation

Frequently Asked Questions

Tell us what you're looking for to find questions and answers about your topic.

We found 584 items

Specify Date Range (Optional):
Select Content Types (Optional):
Current Filters. Click a Filter to Remove It
Policy
Feb. 6, 2004

Memorandum: #04-004, Department of Defense Deployment Biomonitoring Policy and Approved Bioassays for Depleted Uranium and Lead

.PDF | 788.60 KB

The Department has developed criteria for the approval of bioassays to support deployment operations (Attachment 2). Bioassays for Depleted Uranium and lead (Attachments 3 and 4) are approved for use at this time to assess human exposures during or after deployment and combat operations.

  • Identification #: 04-004
  • Type: Memorandum
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Subscribe to updates from the MHS Other Social Media